Synuclein-Beta Polyclonal Antibody

SNCB encodes a member of a small family of proteins that inhibit phospholipase D2 and may function in neuronal plasticity. The Beta-synuclein is abundant in lesions of patients with Alzheimer disease. A mutation in this gene was found in individuals with dementia with Lewy bodies. Alternative splicing results in multiple transcript variants.

The Synuclein-Beta Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Synuclein-Beta protein in various biological samples. This antibody is produced using state-of-the-art technology, ensuring exceptional quality and reliability.

Synuclein-Beta is a protein that plays a crucial role in the pathogenesis of neurodegenerative disorders, particularly Parkinson's disease. The accurate measurement of Synuclein-Beta levels is essential for understanding the underlying mechanisms of these diseases and developing effective therapeutic strategies.

Our Synuclein-Beta Polyclonal Antibody exhibits excellent specificity, binding exclusively to the target protein with minimal cross-reactivity. This antibody has been extensively validated in various experimental settings, including Western blotting, immunohistochemistry, and immunofluorescence, demonstrating consistent and reliable results.

With its high sensitivity, this antibody allows for the detection of even low levels of Synuclein-Beta protein, enabling researchers to accurately quantify its expression in different tissues and cell types. Its robust performance ensures reproducible and precise measurements, facilitating meaningful data interpretation.

Furthermore, this antibody is supplied in a convenient and user-friendly format, making it suitable for a wide range of applications in both research and clinical settings. Its long shelf life and stability ensure consistent performance over time, providing researchers with a reliable tool for their studies.

In summary, the Synuclein-Beta Polyclonal Antibody is a superior reagent that offers exceptional specificity, sensitivity, and reliability for the detection and quantification of Synuclein-Beta protein. Its high-quality performance and versatility make it an invaluable tool for researchers and clinicians working in the field of neurodegenerative disorders.